District shines in MedCity’s new London Life Sciences Report
For London Life Sciences Week, we’re proud to share that 15 companies from the White City Innovation District ecosystem are featured in MedCity‘s new ‘Life Sciences Companies to Watch 2025’ report — key recognition of our vibrant district’s emergence as a leading hub for biotech, medtech, and healthtech innovation.
The report highlights over 60 pioneering companies driving breakthroughs in gene therapy, AI diagnostics, precision medicine and more — and White City Innovation District is proudly at the heart of it.
RISING LIFE SCIENCE STARS
White City Innovation District and WestTech London ecosystem companies highlighted include:
- 30 Technology
- Autolus Therapeutics
- Avacta Therapeutics
- Epsilogen
- DNAe
- MediSieve
- Micrographia Bio
- MiNA Therapeutics
- Mitra Bio
- Mytos
- Orchard Therapeutics
- P.Happi®
- Portal Biotech
- Quell Therapeutics
- Vivan Therapeutics
Download the full report and meet the companies shaping the future.
ABOUT THE REPORT
MedCity’s Life Sciences Companies to Watch 2025 Brochure features a snapshot of the emerging stars across biotech, medtech, healthtech and beyond, which reflect the energy, talent and transformative potential of London’s life sciences sector.
These companies demonstrate the breadth, depth and innovation of scientific research and development in London, which will address some of the biggest future health and research challenges.
Companies were selected by consultation with London’s universities and sector experts, and quantitative selection through data platforms, as outlined in the methodology. An expert panel was assembled to refine a longlist of 120 companies to the final 60 featured.